GAMA
EPZM

Graticule Asia Macro Advisors’s Epizyme, Inc EPZM Stock Holding History

Graticule Asia Macro Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-71,460
Closed -$1.08M – 136
2017
Q2 		$1.08M Buy
+71,460
New +$1.08M 0.05% 102

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Graticule Asia Macro Advisors's EPZM Position: Q3 2017 in Review

Graticule Asia Macro Advisors sold out of Epizyme, Inc (EPZM) in Q3 2017, closing a stake of 71,460 shares — an estimated $1.08M sold.

Graticule Asia Macro Advisors first reported a position in EPZM in Q2 2017 and held it in 1 quarter. The position peaked at $1.08M in Q2 2017. 104 funds tracked by Wall St. Rank hold EPZM as of Q3 2017.

  • Graticule Asia Macro Advisors reported no remaining Epizyme, Inc position as of Q3 2017 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 71,460 Epizyme, Inc shares in Q3 2017, an estimated $1.08M.
  • Graticule Asia Macro Advisors first reported a position in Epizyme, Inc in Q2 2017 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's Epizyme, Inc position peaked at $1.08M in Q2 2017.
  • 104 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2017.

Based on Graticule Asia Macro Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.